Post-earnings recap
Reported
Thu, Apr 28, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's strong EPS performance indicates better-than-expected profitability, but the stock still fell by 1.31%. Investors may be concerned about the lack of revenue details and future guidance. The market reaction suggests uncertainty about the company's growth prospects despite the positive EPS surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.14 | N/A | +242.86% |
| Revenue | N/A | N/A | N/A |
Management expressed cautious optimism regarding their financial performance. They noted the significant EPS beat as a positive indicator.
Management highlighted the strong EPS performance despite the lack of revenue guidance.
They emphasized ongoing efforts in research and development.